Market Overview:
The global cefaclor market is expected to register a CAGR of 3.8% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of bacterial infections and rising demand for cefaclor as an effective antibiotic drug. Based on type, the global cefaclor market is segmented into USP and EP. The USP segment is expected to account for a larger share of the global cefaclor market in 2018. This can be attributed to the growing preference for high-quality drugs by consumers across regions. Based on application, the global cefaclor market is segmented into tablet and capsule forms.
Product Definition:
Cefaclor is a cephalosporin antibiotic prescribed to treat bacterial infections such as bronchitis, sinusitis, and ear infections.
USP:
USP stands for unique selling point and it is a term used in marketing to express the main differentiating factor between two or more products. In pharmaceuticals, USP usually refers to the active ingredients in a medicine that makes it differ from all other similar medicines with respect to its therapeutic effect on patients. The factors that influence the growth of a product can be both internal (involving characteristics of the product itself) and external (relating to competitors).
EP:
Ceclor is the brand name for epinephrine (Adrenaline), a type of medication used to treat an allergic reaction. It works by opening up the airways and increasing blood flow to the area of skin that is affected by allergies. Epinephrine comes in auto-injectors or pre-filled syringes, which makes its administration easier for patients who do not have access to an injection device.
Application Insights:
Cefaclor tablets and capsules are used for the treatment of bacterial infections, such as skin infections, urinary tract infections (UTI), middle ear infection (ME/CVC), and pneumonia. The product is also indicated for the treatment of viral respiratory tract infections (VIRT). In addition, it is employed in the management of chronic bronchitis along with other antibacterial drugs. Furthermore, it finds application in treating acne vulgaris due to its anti-inflammatory property. However, there are no sufficient data supporting its use for these indications.
The market has been segmented into North America; Europe; Asia Pacific; Latin America; and Middle East & Africa on the basis of application into tablet form or capsule form segments.
Regional Analysis:
North America was the second-largest regional market in 2017. The region is expected to maintain its position through the forecast period on account of high CAGR in U.S. and Canada, which are major markets for this drug.
Asia Pacific is estimated to be one of the fastest-growing regions during the forecast years owing to rising cases of malaria across India, China, Indonesia, Malaysia & Singapore as well as other countries within APAC region.
Growth Factors:
- Increasing prevalence of bacterial infections: The increasing prevalence of bacterial infections is one of the key growth drivers for the cefaclor market. This is because cefaclor is an effective antibiotic against a wide range of bacteria.
- Rising demand for generic drugs: The rising demand for generic drugs across the globe is another key growth driver for the cefaclor market. This is because generic drugs are cheaper than branded drugs and are equally effective in treating diseases.
- Growing awareness about antibiotics: The growing awareness about antibiotics among people worldwide is another key growth driver for the cefaclor market. This is because antibiotics play an important role in treating various types of infections caused by bacteria, viruses, and other microorganisms.
Scope Of The Report
Report Attributes
Report Details
Report Title
Cefaclor Market Research Report
By Type
USP, EP
By Application
Tablet, Capsule
By Companies
Union Chempharma, NCPC, Qilu Antibiotics, Lupin Pharmaceuticals, Fukang, Dongying Pharmaceutical, Alkem, SALUBRIS, LIVZON, CSPC, Union Chempharma, LKPC, HPGC, Huafangpharm
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
162
Number of Tables & Figures
114
Customization Available
Yes, the report can be customized as per your need.
Global Cefaclor Market Report Segments:
The global Cefaclor market is segmented on the basis of:
Types
USP, EP
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tablet, Capsule
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Union Chempharma
- NCPC
- Qilu Antibiotics
- Lupin Pharmaceuticals
- Fukang
- Dongying Pharmaceutical
- Alkem
- SALUBRIS
- LIVZON
- CSPC
- Union Chempharma
- LKPC
- HPGC
- Huafangpharm
Highlights of The Cefaclor Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- USP
- EP
- By Application:
- Tablet
- Capsule
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cefaclor Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cefaclor is a cephalosporin antibiotic. It is used to treat infections caused by bacteria, such as pneumonia, bronchitis, and urinary tract infections.
Some of the major companies in the cefaclor market are Union Chempharma, NCPC, Qilu Antibiotics, Lupin Pharmaceuticals, Fukang, Dongying Pharmaceutical, Alkem, SALUBRIS, LIVZON, CSPC, Union Chempharma, LKPC, HPGC, Huafangpharm.
The cefaclor market is expected to register a CAGR of 3.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cefaclor Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cefaclor Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cefaclor Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cefaclor Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cefaclor Market Size & Forecast, 2020-2028
4.5.1 Cefaclor Market Size and Y-o-Y Growth
4.5.2 Cefaclor Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 USP
5.2.2 EP
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Tablet
6.2.2 Capsule
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cefaclor Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cefaclor Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 USP
9.6.2 EP
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Tablet
9.10.2 Capsule
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 USP
10.6.2 EP
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Tablet
10.10.2 Capsule
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 USP
11.6.2 EP
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Tablet
11.10.2 Capsule
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 USP
12.6.2 EP
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Tablet
12.10.2 Capsule
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 USP
13.6.2 EP
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Tablet
13.10.2 Capsule
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cefaclor Market: Competitive Dashboard
14.2 Global Cefaclor Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Union Chempharma
14.3.2 NCPC
14.3.3 Qilu Antibiotics
14.3.4 Lupin Pharmaceuticals
14.3.5 Fukang
14.3.6 Dongying Pharmaceutical
14.3.7 Alkem
14.3.8 SALUBRIS
14.3.9 LIVZON
14.3.10 CSPC
14.3.11 Union Chempharma
14.3.12 LKPC
14.3.13 HPGC
14.3.14 Huafangpharm
